Topical treatment of periocular basal cell epithelioma with solcoderm

Esther Azizi; David Semach; Miriam Schewach-Millet; Issac Avni; Oded Ben-Haim; Giora Treister; Michael Blumenthal; Michael Belkin

doi:10.1159/000309395

Topical treatment of periocular basal cell epithelioma with solcoderm

Esther Azizi^*, David Semach, Miriam Schewach-Millet, Issac Avni, Oded Ben-Haim, Giora Treister, Michael Blumenthal, Michael Belkin

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

25 patients with 29 histologically confirmed periocular basal cell epitheliomas were treated by topical application of Solcoderm, a solution of organic and inorganic acids and ions. The cure rate of the 29 lesions, which were followed for a mean period of 32 months, was 80%. The overall cure rate following second Solcoderm treatment of the 6 recurrent lesions was 96.7%. The cosmetic and functional results were excellent and there were no serious complications and side effects.

Original language	English
Pages (from-to)	116-120
Number of pages	5
Journal	Ophthalmologica
Volume	189
Issue number	3
DOIs	https://doi.org/10.1159/000309395
State	Published - 1984

Keywords

Basal cell epithelioma
Eyelid tumors
Solcoderm
Topical treatment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000309395

Cite this

@article{b780aed2cdd24e76b7904ac993135015,

title = "Topical treatment of periocular basal cell epithelioma with solcoderm",

abstract = "25 patients with 29 histologically confirmed periocular basal cell epitheliomas were treated by topical application of Solcoderm, a solution of organic and inorganic acids and ions. The cure rate of the 29 lesions, which were followed for a mean period of 32 months, was 80%. The overall cure rate following second Solcoderm treatment of the 6 recurrent lesions was 96.7%. The cosmetic and functional results were excellent and there were no serious complications and side effects.",

keywords = "Basal cell epithelioma, Eyelid tumors, Solcoderm, Topical treatment",

author = "Esther Azizi and David Semach and Miriam Schewach-Millet and Issac Avni and Oded Ben-Haim and Giora Treister and Michael Blumenthal and Michael Belkin",

year = "1984",

doi = "10.1159/000309395",

language = "אנגלית",

volume = "189",

pages = "116--120",

journal = "Ophthalmologica",

issn = "0030-3755",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - Topical treatment of periocular basal cell epithelioma with solcoderm

AU - Azizi, Esther

AU - Semach, David

AU - Schewach-Millet, Miriam

AU - Avni, Issac

AU - Ben-Haim, Oded

AU - Treister, Giora

AU - Blumenthal, Michael

AU - Belkin, Michael

PY - 1984

Y1 - 1984

N2 - 25 patients with 29 histologically confirmed periocular basal cell epitheliomas were treated by topical application of Solcoderm, a solution of organic and inorganic acids and ions. The cure rate of the 29 lesions, which were followed for a mean period of 32 months, was 80%. The overall cure rate following second Solcoderm treatment of the 6 recurrent lesions was 96.7%. The cosmetic and functional results were excellent and there were no serious complications and side effects.

AB - 25 patients with 29 histologically confirmed periocular basal cell epitheliomas were treated by topical application of Solcoderm, a solution of organic and inorganic acids and ions. The cure rate of the 29 lesions, which were followed for a mean period of 32 months, was 80%. The overall cure rate following second Solcoderm treatment of the 6 recurrent lesions was 96.7%. The cosmetic and functional results were excellent and there were no serious complications and side effects.

KW - Basal cell epithelioma

KW - Eyelid tumors

KW - Solcoderm

KW - Topical treatment

UR - http://www.scopus.com/inward/record.url?scp=0021160190&partnerID=8YFLogxK

U2 - 10.1159/000309395

DO - 10.1159/000309395

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 6493689

AN - SCOPUS:0021160190

SN - 0030-3755

VL - 189

SP - 116

EP - 120

JO - Ophthalmologica

JF - Ophthalmologica

IS - 3

ER -

Topical treatment of periocular basal cell epithelioma with solcoderm

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this